Interleukin-6 blockade with tocilizumab in COVID-19: Does it live up to its hype?

Chia Siang Kow; Syed Shahzad Hasan

doi:10.1016/j.pulmoe.2020.10.004

Interleukin-6 blockade with tocilizumab in COVID-19: Does it live up to its hype?

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	86-87
Number of pages	2
Journal	Pulmonology
Volume	27
Issue number	1
Early online date	21 Oct 2020
DOIs	https://doi.org/10.1016/j.pulmoe.2020.10.004
Publication status	Published - 1 Jan 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.pulmoe.2020.10.004Licence: CC BY-NC-ND

Cite this

@article{986e006b482849e78c6c2b0a0f91cbea,

title = "Interleukin-6 blockade with tocilizumab in COVID-19: Does it live up to its hype?",

keywords = "Tocilizumab, COVID-19, Coronavirus 2019",

author = "Kow, \{Chia Siang\} and Hasan, \{Syed Shahzad\}",

year = "2021",

month = jan,

day = "1",

doi = "10.1016/j.pulmoe.2020.10.004",

language = "English",

volume = "27",

pages = "86--87",

journal = "Pulmonology",

issn = "2531-0437",

publisher = "Taylor and Francis Ltd.",

number = "1",

}

TY - JOUR

T1 - Interleukin-6 blockade with tocilizumab in COVID-19

T2 - Does it live up to its hype?

AU - Kow, Chia Siang

AU - Hasan, Syed Shahzad

PY - 2021/1/1

Y1 - 2021/1/1

KW - Tocilizumab

KW - COVID-19

KW - Coronavirus 2019

UR - https://www.scopus.com/pages/publications/85098149508

U2 - 10.1016/j.pulmoe.2020.10.004

DO - 10.1016/j.pulmoe.2020.10.004

M3 - Letter

C2 - 33158786

SN - 2531-0437

VL - 27

SP - 86

EP - 87

JO - Pulmonology

JF - Pulmonology

IS - 1

ER -

Interleukin-6 blockade with tocilizumab in COVID-19: Does it live up to its hype?

UN SDGs

Access to Document

Other files and links

Cite this